News
HLN
9.82
+4.47%
0.42
Haleon CFO Dawn Allen sells shares worth £469,794 to cover tax liabilities
PUBT · 2d ago
Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.
Barchart · 2d ago
Why Microsoft Stock Surged Today
The Motley Fool · 3d ago
Haleon PLC (HLN) Gets a Sell from Deutsche Bank
TipRanks · 3d ago
“Better Everyday Health to Consumers Globally”: Microsoft Stock (NASDAQ:MSFT) Jumps With Haleon Team-Up
TipRanks · 3d ago
Microsoft Stock (MSFT) Jumps 3% as Haleon (HLN) Deepens 5-Year Al Partnership
TipRanks · 3d ago
Haleon Bets on Microsoft AI To Support Growth and Reach One Billion More Consumers by 2030
Benzinga · 3d ago
Haleon inks five-year partnership with Microsoft
Seeking Alpha · 3d ago
Haleon announces new five-year collaboration with Microsoft
TipRanks · 3d ago
HALEON - CO AND MICROSOFT TO CO-CREATE AI USE CASES ACROSS KEY BUSINESS FUNCTIONS
Reuters · 3d ago
Haleon partners with Microsoft in five-year AI, cloud collaboration
PUBT · 3d ago
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration
Barchart · 4d ago
Jefferies Sticks to Their Buy Rating for Haleon PLC (HLN)
TipRanks · 4d ago
Haleon partners with Microsoft in five-year deal to scale AI capabilities
PUBT · 5d ago
Weekly Report: what happened at HLN last week (0622-0626)?
Weekly Report · 5d ago
Barclays Sticks to Their Buy Rating for Haleon PLC (HLN)
TipRanks · 5d ago
Haleon guides for FY 2026 organic revenue growth of 3%-5% in pre-close brief
PUBT · 5d ago
UK Stocks-Factors to watch on June 29
Reuters · 5d ago
J.P. Morgan Reaffirms Their Sell Rating on Haleon PLC (HLN)
TipRanks · 06/25 21:57
Haleon price target lowered to 315 GBp from 335 GBp at JPMorgan
TipRanks · 06/25 17:45
More
Webull provides a variety of real-time HLN stock news. You can receive the latest news about Haleon through multiple platforms. This information may help you make smarter investment decisions.
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.